Journal
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 11, Issue 4, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2022-006434
Keywords
cell engineering; immunotherapy; adoptive; killer cells; natural; lymphocytes; tumor-infiltrating; receptors; chimeric antigen
Categories
Ask authors/readers for more resources
Cell therapy is a growing field that involves the use of various types of immune cells, including T cells, for the treatment of human ailments such as cancer. This review focuses on cell therapy in the immuno-oncology space, discussing recent advances in different cell therapies and strategies to enhance therapeutic responses. Additionally, potential alternative immune cell types are explored to overcome the limitations of conventional adoptive cell therapies.
Cell therapy encompasses an expanding spectrum of cell-based regimes for the treatment of human ailments, such as the use of immune cells, in particular T cells, for combating tumors and the modulation of inflammatory immune responses. In this review, we focus on cell therapy in the immuno-oncology space, which is largely driven by interests and demands from the clinics for better solutions to target various hard-to-treat cancers. We discuss recent advances in various types of cell therapies, including T cell receptor-T cells, chimeric antigen receptor (CAR)-T cells, tumor-infiltrating lymphocytes and natural killer cells. Particularly, the present review focuses on the strategies to improve therapeutic responses by either enhancing tumor recognition or the resilience of infused immune cells within tumor microenvironment. Finally, we discuss the potential of other innate or innate-like immune cell types currently being explored as promising CAR-cell alternatives that seek to address the limitations of conventional adoptive cell therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available